Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome

被引：2
|
作者：
De, Surya K. [1 ,2 ]
机构：
[1] Conju Probe, San Diego, CA 92121 USA
[2] Bharath Univ, Dept Chem, Chennai, Tamil Nadu, India
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
关键词：
idelalisib; duvelisib; copanlisib; alpelisib; leniolisib; phosphatidylinositol; 3-kinase; PI3K/AKT SIGNALING PATHWAY; PI3K-DELTA; DISCOVERY;
D O I：
10.3389/fphar.2024.1337436
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
(Figure presented.) Copyright © 2024 De.
引用
收藏
页数：7
相关论文
共 50 条
  • [11] Activated Phosphoinositide 3 Kinase Delta Syndrome (APDS): A Primary Immunodeficiency Mimicking Lymphoma
    Baleydier, Frederic
    Ranza, Emmanuelle
    Schappi, Michela
    Rougemont, Anne-Laure
    Merlini, Laura
    Ansari, Marc
    Blanchard-Rohner, Geraldine
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (08) : E521 - E524
  • [12] A NOVEL PIK3CD MUTATION SUSPECTED TO CAUSE ACTIVATED PHOSPHOINOSITIDE 3-KINASE-DELTA SYNDROME (APDS)
    Ortiz, H.
    Rana, R.
    Davila, N. Fernandez
    Vargas-Hernandez, A.
    Forbes, L.
    Hasan, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S165 - S165
  • [13] A Novel Role of Phosphoinositide-3 Kinaseγ Inhibition in Suppressing Heart Allograft Rejection
    Akiyoshi, Takurin
    Azzi, Jamil
    El-Haddad, Najib
    Wong, Macie
    Yang, Sunmi
    Moore, Robert F.
    Rodig, Scott J.
    Sayegh, Mohamed H.
    Abdi, Reza
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 213 - 213
  • [14] A 24-Year-Old Male With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) With Novel Deletion
    D'Astous-Gauthier, Katherine
    Chapdelaine, Hugo
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S11 - S11
  • [15] THE ROLE OF A PHOSPHOINOSITIDE-3 KINASE INHIBITOR IN VASCULAR INFLAMMATION
    Chaudhry, H. A.
    Kodji, X.
    Cerutti, C.
    Argunhan, F.
    Ridley, A.
    Brain, S. D.
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 286 - 286
  • [16] A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3KS) syndrome (APDS): Adolescent and adult subgroup analysis
    Rao, V. Koneti
    Sediva, Anna
    Dalm, Virgil A. S. H.
    Plebani, Alessandro
    Schuetz, Catharina
    Shcherbina, Anna
    Trizzino, Antonino
    Zharankova, Yulia
    Orpia, Alanvin
    Kulm, Elaine
    Webster, Sharon
    Koerholz, Julia
    Lougaris, Vassilios
    Rodina, Yulia
    Conlon, Niall
    Coulter, Tanya
    Bradt, Jason
    Relan, Anurag
    Uzel, Gulbu
    CLINICAL IMMUNOLOGY, 2025, 270
  • [17] Multiple Functions of Phosphoinositide-3 Kinase Enhancer (PIKE)
    Chan, Chi Bun
    Ye, Keqiang
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 613 - 623
  • [18] Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome
    Rae, William
    Ramakrishnan, Kesava A.
    Gao, Yifang
    Ashton-Key, Margaret
    Pengelly, Reuben J.
    Patel, Sanjay V.
    Ennis, Sarah
    Williams, Anthony P.
    Faust, Saul N.
    CLINICAL IMMUNOLOGY, 2016, 171 : 38 - 40
  • [19] The role of a phosphoinositide-3 kinase inhibitor in vascular inflammation
    Chaudhry, H.
    Cerutti, C.
    Kodji, X.
    Argunhan, F.
    Ridley, A.
    Brain, S. D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 308 - 308
  • [20] THE PHOSPHOINOSITIDE-3 KINASE SURVIVAL SIGNALING MECHANISM IN SEPSIS
    Manukyan, Mariuxi C.
    Weil, Brent R.
    Wang, Yue
    Abarbanell, Aaron M.
    Herrmann, Jeremy L.
    Poynter, Jeffrey A.
    Meldrum, Daniel R.
    SHOCK, 2010, 34 (05): : 442 - 449
12345